Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids. [electronic resource]

By:

Amminger, G P

Contributor(s):

Mechelli, A
Rice, S
Kim, S-W
Klier, C M
McNamara, R K
Berk, M
McGorry, P D
Schäfer, M R

Producer: 20150909Description: e495 p. digitalISSN:

2158-3188

Subject(s):

Adolescent
Adult
Arachidonic Acid -- metabolism
Docosahexaenoic Acids -- metabolism
Double-Blind Method
Eicosapentaenoic Acid -- metabolism
Erythrocyte Membrane -- metabolism
Fatty Acids -- metabolism
Fatty Acids, Omega-3 -- therapeutic use
Fatty Acids, Unsaturated -- metabolism
Female
Humans
Linear Models
Linoleic Acid -- metabolism
Male
Multivariate Analysis
Psychotic Disorders -- drug therapy
Risk
Treatment Outcome
Vitamin E -- therapeutic use
Vitamins -- therapeutic use
Young Adult
alpha-Linolenic Acid -- metabolism

Online resources:

Available from publisher's website

In: Translational psychiatry vol. 5

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

There are no comments on this title.

Browse results Close

Back to results

41 [Thrombocytopenia and thrombocytopathy in neonates and infants].
by Brolíková, D
42 [Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation].
by Prikryl, P
43 [Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia].
by Penka, M
44 [Significance of urokinase and its inhibitors in the invasiveness and metastasing of malignant tumors].
by Halámková, J
45 Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors.
by Blatny, J
46 Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
by Husa, P
47 [Preparation of patients on anticoagulant treatment for invasive surgery].
by Brejcha, M
48 Hemocoagulation disorders in extensively burned patients: pilot study for scoring of the DIC.
by Lipový, B
49 High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.
by Aswad, M H
50 Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies.
by Kubesová, H
51 Sample processing and methodological pitfalls in multiple myeloma research.
by Potácová, A
52 [Warning signs preceding the development of septic shock in patients with neutropenia treated for hematologic malignancies].
by Kubesová, H
53 [Involvement of the cardiac muscle in anemia].
by Elbl, L
54 Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.
by Salaj, P
55 [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012].
by Penka, M
56 Minimal Residual Disease Assessment in Multiple Myeloma by Multiparametric Flow Cytometry.
by Rihova, L
57 [The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery].
by Penka, M
58 Severe postpartum haemorrhage treated with recombinant activated factor VII in 80 Czech patients: analysis of the UniSeven registry.
by Blatný, J
59 Biobanking - the First Step to Successful Liquid Biopsy Experiments.
by Almasi, M
60 Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapy.
by Ocadlikova, Darina

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.

APA

Amminger G. P., Mechelli A., Rice S., Kim S., Klier C. M., McNamara R. K., Berk M., McGorry P. D. & Schäfer M. R. (20150909). Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids. : Translational psychiatry.

Chicago

Amminger G P, Mechelli A, Rice S, Kim S-W, Klier C M, McNamara R K, Berk M, McGorry P D and Schäfer M R. 20150909. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids. : Translational psychiatry.

Harvard

Amminger G. P., Mechelli A., Rice S., Kim S., Klier C. M., McNamara R. K., Berk M., McGorry P. D. and Schäfer M. R. (20150909). Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids. : Translational psychiatry.

MLA

Amminger G P, Mechelli A, Rice S, Kim S-W, Klier C M, McNamara R K, Berk M, McGorry P D and Schäfer M R. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids. : Translational psychiatry. 20150909.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC